CXCR4 and Miyoshi myopathy: Furthermore, blocking CXCL12 binding to CXCR4 with the plerixafor (AMD3100) inhibitor disrupts MM cell interaction with the BM microenvironment (119), causing MM cell mobilization into the circulation (120) (Figure 1).